| For: | Wang YJ, Wang YL, Jiang XF, Li JE. Molecular targets and mechanisms of Jiawei Jiaotai Pill on diabetic cardiomyopathy based on network pharmacology. World J Diabetes 2023; 14(11): 1659-1671 [PMID: 38077804 DOI: 10.4239/wjd.v14.i11.1659] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v14/i11/1659.htm |
| Number | Citing Articles |
| 1 |
Tingting Liu, Xu Wang, Jing Liu, Saisai Yang, Qiyao Li, Jubin Zhang, Xiuhong Wu. Analysis of Chemical Constituents of Jiaotai Pill Based on UPLC-Q-Exactive Orbitrap-HRMS Technology and Its Antidiabetic Type 2 Mechanism in Network Pharmacology. Current Pharmaceutical Design 2026; 32(19) doi: 10.2174/0113816128402177250911093207
|
| 2 |
Su-Rui Lu, Zi-Xiang Fu, Yan Xia, Yan-Mei Xu, Feng-Liang Wang, Zhao-Wen Pan, Yi-Wei Tu, Wen-Jing Peng, Ming-Li Han, Wei Yu, Wen-Liang Zha. Exploring the potential molecular targets and therapeutic mechanisms of Cyperi Rhizoma in treating diabetic cardiomyopathy: a computational approach. RSC Advances 2025; 15(29) doi: 10.1039/D5RA02505B
|